HAE PROPHYLAXIS BY TARGETING PREKALLIKREIN WITH SIRNA- PHASE 1 INTERIM SAFETY OUTCOMES AND PREKALLIKREIN LEVELS

be reproducible across three sites and nine operators, with no measurable between-site bias and 3.75% between-operator error determined by ANOVA.Importantly, the success rate of obtaining valid fingerstick samples was found to be comparable to venipuncture.Conclusion: Our POC device demonstrated clinical equivalence to the reference method for total IgE measurement.It provides a compelling, efficient alternative to conventional venipuncture for laboratory IgE quantification. P046